Skip to content
OpenCapital
Get started

Arbutus Biopharma Corporation ABUS Other Research And Development Expense

Other Research And Development Expense at other companies

Celanese Corporation logo
Celanese CorporationCE
$0—
Corvex logo
Corvex MOVE
$899K+12.4%
Disc Medicine logo
Disc MedicineIRON
$2.17M+18.2%
TG Therapeutics logo
TG TherapeuticsTGTX
$43.52M+1.1%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.49M+25.5%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$2.86M+3.1%

Segments

By segment

See full
Reportable Segment$2.7M-44.7%

Other financials

Income statement

See full
Revenue$179.1M+10,055%
Operating income$168.9M+757%
Net income$169.7M+792%
EPS (diluted)$0.87+769%

Balance sheet

See full
Cash & equivalents$23.7M-36.1%
Total debt$631.0K-46.9%
Total equity$260.2M+229%
Total assets$277.2M+137%

Cash flow

See full
Operating cash flow-$8.1M+39.4%
CapEx--100%
Free cash flow-$4.7M+55.0%

Valuation

See full
Market cap$871.14M+32.6%
Enterprise value$848.07M+36.6%
P/E5.4×—
P/S4.6×-98.0×

Profitability

See full
Operating margin81.7%+42.1pp
Net margin84%+43.4pp
FCF margin-281.5%-119pp

Returns & leverage

See full
Return on equity94.7%+65.1pp
Debt / equity0×0.0×
Current ratio54.3×+48.3×